Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “N Meningitidis Serogroup B”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Large-scale testing (Phase 3)Study completedNCT01214850
What this trial is testing

Novartis Vaccine and Diagnostics Carriage Trial

Who this might be right for
N. Meningitidis Carriage
Novartis Vaccines 2,968
Testing effectiveness (Phase 2)Study completedNCT00774384
What this trial is testing

Regulation of Mucosal Immune Response to Systemic MenB Vaccine

Who this might be right for
Meningococcal Infections
University Hospitals Bristol and Weston NHS Foundation Trust 9
Post-approval studies (Phase 4)Looking for participantsNCT07197762
What this trial is testing

MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young Adults

Who this might be right for
Neisseria Meningitidis
Emory University 125
Post-approval studies (Phase 4)Study completedNCT02569632
What this trial is testing

Investigating the Immunogenicity of a U.S.-Licensed Meningococcal Serogroup B Vaccine (Trumenba)

Who this might be right for
Meningococcal Infections
UCSF Benioff Children's Hospital Oakland 18
Testing effectiveness (Phase 2)Study completedNCT00129116
What this trial is testing

3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 388
Not applicableStudy completedNCT00161941
What this trial is testing

Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216

Who this might be right for
Meningococcal Meninigitis, Serogroup C
Pfizer 321
Large-scale testing (Phase 3)Study completedNCT00161928
What this trial is testing

Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants

Who this might be right for
Meningitis, Meningococcal
Pfizer 330
Testing effectiveness (Phase 2)Study completedNCT00721396
What this trial is testing

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules

Who this might be right for
Meningococcal Infections
Novartis Vaccines 1,885
Testing effectiveness (Phase 2)Study completedNCT01461980
What this trial is testing

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Who this might be right for
VaccinesMeningococcal Vaccines
Pfizer 2,648
Testing effectiveness (Phase 2)Study completedNCT00443157
What this trial is testing

Meningococcal B Vaccination in University Students

Who this might be right for
Neisseria Meningitidis Serogroup B
Public Health England 50
Large-scale testing (Phase 3)Study completedNCT01553279
What this trial is testing

Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)

Who this might be right for
Neisseria MeningitidisBacterial InfectionsVirus Diseases
MCM Vaccines B.V. 284
Large-scale testing (Phase 3)Study completedNCT00891176
What this trial is testing

Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 582
Testing effectiveness (Phase 2)Study completedNCT02531698
What this trial is testing

Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to <10 Years

Who this might be right for
MENINGOCOCCAL INFECTION
Pfizer 400
Post-approval studies (Phase 4)Study completedNCT00454987
What this trial is testing

Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine

Who this might be right for
Haemophilus Influenzae Type bNeisseria MeningitidisNeisseria Meningitidis-Haemophilus Influenzae Type b Vaccine
GlaxoSmithKline 288
Large-scale testing (Phase 3)Study completedNCT00289783
What this trial is testing

Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 4,441
Early research (Phase 1)Looking for participantsNCT07395739
What this trial is testing

A Phase I Clinical Trial to Assess the Safety and Immunogenicity of DX-104

Who this might be right for
Neisseria Meningitidis Serogroup B
Shanghai Yuguan Biotech Co., Ltd.（Delonix Bioworks) 30
Large-scale testing (Phase 3)Study completedNCT02305446
What this trial is testing

Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ.

Who this might be right for
Meningitis, Meningococcal, Serogroup B
Novartis 55
Large-scale testing (Phase 3)Study completedNCT00326118
What this trial is testing

Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 433
Large-scale testing (Phase 3)Study completedNCT00661713
What this trial is testing

Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine Administered to Healthy Adolescents According to Different Vaccination Schedules

Who this might be right for
Meningococcal Disease
Novartis Vaccines 1,631
Large-scale testing (Phase 3)Study completedNCT00228917
What this trial is testing

Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children

Who this might be right for
Whole Cell PertussisTetanusHepatitis B+3 more
GlaxoSmithKline 798
Next Page